Pathogenesis of dilated cardiomyopathy and heart failure: Insights from cell morphology and biology

Current Opinion in Cardiology

Volumn 11, Issue 3, 1996, Pages 293-301

  Hein, Stefan ^a   Schaper, Jutta ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA ADRENERGIC RECEPTOR; CALCIUM; CONNECTIN;

CELL STRUCTURE; CHROMOSOME ABERRATION; CYTOLOGY; HEART DILATATION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM;

ANIMALS; AUTOIMMUNITY; CALCIUM; CARDIOMYOPATHY, DILATED; CRICETINAE; DISEASE MODELS, ANIMAL; DOGS; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; MYOCARDIAL CONTRACTION; RATS;

EID: 0029935950     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199605000-00010     Document Type: Review

References (58)

1. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980, 44:672-673.
2. Dec GW, Fuster V: Idiopathic dilated cardiomyopathy. N Engl J Med 1994, 331:1564-1575.
3. Kasper EK, Agema WRP, Hutchins GM, Deckers JW, Hare JM, Baughman KL: The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994, 23:586-590.
4. Durand JB, Bachinski LL, Bieling LC, Czernuszewicz GZ, Abchee AB, Yu QT, Tapscott T, Hill R, Ifegwu J, Marian AJ, Brugada R, Daiger S, Gregoritch JR, Anderson JL, Quinones M, Towbin JA, Roberts R: Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 1995, 92:3387-3389. This study is the first to describe chromosomal aberrations in DCM.
5. Krajinovic M, Pinamonti B, Sinagra G, Vatta M, Severini GM, Milasin J, Falaschi A, Camerini F, Giacca M, Mestroni L: Heart muscle disease study group: linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet 1995, 57:846-852.
6. Franz WM, Cremer M, Herrmann R, Grunig E, Fogel W, Scheffold T, Goebel HH, Kircheisen R, Kübler W, Volt T: X-linked dilated cardiomyopathy: novel mutation of the dystrophin gene. Ann N Y Acad Sci 1995, 752:470-491.
7. Muntoni F, Wilson L, Marrosu G, Marrosu MG, Cianchetti C, Mestroni L, Ganau A, Dubowitz V, Sewry C: A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart J Clin Invest 1995, 96:693-699.
8. Muntoni F, Melis MA, Ganau A, Dubowitz V: Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. Am J Hum Genet 1995, 56:151-157.
9. Oldfors A, Erikson BO, Kyllerman M, Martinsson T, Wahlström J: Dilated cardiomyopathy and the dystrophin gene: an illustrated review. Br Heart J 1994, 72:344-348.
10. Holt JC, Caulfield JB, Norton P, Chantler PD, Slayter HS, Margossian SS: Human cardiac myosin light chains: sequence comparison between myosin LC1 and LC2 from normal and idiopathic dilated cardiomyopathic hearts. Mol Cell Biochem 1995, 145:89-96.
11. Li YY, Hengstenberg C, Maisch B: Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy. Biochem Biophys Res Commun 1995, 210:211-218.
12. Lauer B, Padberg K, H.P. S, Strauer B-E: Autoantikörper gegen kardiales Myosin bei Patienten mit Moyokarditis und dilatativer Kardiomyopathie [in German]. Z Kardiol 1995, 84:301-310.
13. Goldman JH, McKenna WJ: Immunopathogenesis of dilated cardiomyopathies. Curr Opin Cardiol 1995, 10:306-311.
14. Schultheiss HP, Schulze K, Schauer R, Witzenbichler B, Strauer BE: Antibody-mediated imbalance of myocardial energy metabolism: a causal factor of cardiac failure? Circ Res 1995, 76:64-72.
15. Limas CJ, Goldenberg IF, Limas C: Soluble interieukin-2 receptor levels in patients with dilated cardiomyopathy. Circulation 1995, 91:631-634. Important study showing the activation of immune competent cells and the production of autoantibodies in DCM.
16. Holzinger C, Scholhammer A, Imhof M, Reinwald C, Kramer G, Zuckermann A, Wolner E, Steiner G: Phenotypic patterns of mononuclear cells in dilated cardiomyopathy. Circulation 1995, 92:2876-2885.
17. 2+ and ATP-cycling imbalances in end-stage dilated and ischemic cardiomyopathies. Cardiovasc Res 1995, 30:394-404.
18. 2+ uptake in DCM.
19. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G: Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995, 92:778-784.
20. 2+ ATPase may therefore determine systolic behavior.
21. Beuckelmann DJ, Nabauer M, Kruger C, Erdmann E: Alterad diastolic [Ca2+](i) handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J 1995, 129:684-689.
22. Wolff MR, Whitesell LF, Moss RL: Calcium sensitivity of isometric tension is increased in canine experimental heart failure. Circ Res 1995, 76:781-789.
23. Keller E, Schomisch-Moravec CH, Bond M: Altered subcellular Ca 2+ regulation in papillary muscles from cardiomyopathic hamster hearts. Am J Physiol 1995, 268:H1875-1883.
24. Eschenhagen T, Diederich M, Kluge SH, Magnussen O, Mene U, Muller F, Schmitz W, Scholz H, Weil J, Sent U, Schaad A, Scholtysik G, Wuthrich A, Gaillard C: Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy. J Mol Cell Cardiol 1995, 27:357-370.
25. Obrien PJ, Duke AL, Shen H, Shohet RV: Myocardial mRNA content and stability, and enzyme activities of Ca-cycling and aerobic metabolism in canine dilated cardiomyopathies. Mol Cell Biochem 1995, 142:139-150.
26. Go LO, Moschella MC, Watras J, Handa KK, Fyle BS, Marks AR: Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995, 95:888-894.
27. Böhm M, Lohse MJ: Quantification of β-adrenoreceptors and β- adrenoreceptor kinase on protein and mRNA levels in heart failure. Eur Heart J 1994, 15:30-34. Excellent review article.
28. Spinale FG, Temple GE, Mukherjee R, Eble DM, Brown R, Vacchiano CA, Zile MR: Cellular and molecular alterations in the β-adrenergic-system with cardiomyopathy Induced by tachycardia. Cardiovasc Res 1994, 28:1243-1250.
29. Alpert N, Mulieri L, Hasenfuss G, Holubarsch C: Myocyte reorganisation in hypertrophied and failing hearts. Eur Heart J 1995, 16(suppl C):2-7. An excellent study on isolated myocytes from failing human hearts, showing reduced functional capacity of these cells.
30. Delmonte F, Ogara P, Poole-Wilson PA, Yacoub M, Harding SE: Cell geometry and contractile abnormalities of myocytes from from failing human left ventricle. Cardiovasc Res 1995, 30:281-290. An excellent study on isolated myocytes from failing human hearts showing reduced functional capacity of these cells.
31. Davies C, Davia K, Bennett J, Pepper J, Poole-Wilson P, Harding S: Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 1995, 92:2540-2549. An excellent study on isolated myocytes from failing human hearts showing reduced functional capacity of these cells.
32. Hein S, Scholz D, Fujitani N, Rennollet H, Brand T, Friedl A, Schaper J: Altered expression of titin and contractile proteins in falling human myocardium. J Mol Cell Cardiol 1994, 26:1291-1306. First immunohistochemical description of titin abnormalities in human DCM.
33. Anderson PAW, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK: Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult and failing heart. Circ Res 1995, 76:681-686.
34. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P: The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995, 27:291-305. Careful microscopic analysis and definition of hypertrophy and chamber dilatation in human DCM.
35. Gerdes AM, Capasso JM: Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol 1995, 27:849-856.
36. Schaper J, Hein S, Scholz D, Mollnau H: Multifaceted morphological alterations are present in the failing human heart J Mol Cell Cardiol 1995, 27:857-861.
37. Poole-Wilson PA: The dimension of human cardiac myocytes: confusion caused by methodology and pathology. J Mol Cell Cardiol 1995, 27:863-865. Critical review on the question of changes in myocyte size.
38. Quaini F, Cigola E, Lagrastra C, Saccani G, Quaini E, Rossi C, Olivetti G, Anversa P: End-stage cardiac failure in humans is coupled with the induction of proliferative cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 1994, 75:1050-1063.
39. Morano I, Hadicke K, Grom S, Koch A, Schwinger RHG, Bohm M, Bartel S, Erdmann E, Krause EG: Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol 1994, 26:361-368.
40. Knecht M, Regitz-Zagrosek V, Pleissner KP, Jungblut P, Steffen C, Hildebrandt A, Fleck E: Characterisation of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur Heart J 1994, 15(suppl D):37-44.
41. Mollnau H, Münkel B, Schaper J: Collagen VI in the extracellular matrix of normal and failing human myocardium. Herz 1995, 20:89-94.
42. Marijianowski MMH, Teeling P, Mann J, Becker AE: Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment J Am Coll Cardiol 1995, 25:1263-1272.
43. Paul M, Pinto YM, Schunkert H, Ganten D, Böhm M: Activation of the renin-angiotensin system in heart failure and hypertrophy: studies in human hearts and transgenic rats. Eur Heart J 1994, 15:63-67.
44. Weber KT, Brilla CG, Campbell SE, Reddy HK: Myocardial fibrosis and the concepts of cardioprotection and cardioreparation. J Hypertens 1992, 10:S87-S94.
45. Brilla CG, Maisch B: Regulation of the structural remodeling of the myocardium: from hypertrophy to heart failure. Eur Heart J 1994, 15:45-53.
46. Lin X, Hänze J, Heese F, Sodmann R, Lang R: Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 1995, 77:750-758.
47. Nogami K, Kusachi S, Niiya K, Moritani H, Tsuji T: Changes in extracellular matrix components in cardiomyopathic Syrian hamster, BIO 14.6. Jpn Circ J 1995, 59:631-640.
48. Kawaguchi N, Fujitani N, Schaper J, Onishi S: Pathological changes of myocardial cytoskeleton in cardiomyopathic hamster. Mol Cell Biochem 1995, 144:75-79.
49. Spinale FG, Holzgrefe HH, Mukherjee R, Hird RB, Walker JD, Arnimbarker A, Powell JR, Koster WH: Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation 1995, 92:562-578. Detailed analysis of cellular events in the pacing-induced DCM model in the dog.
50. Spinale FG, Holzgrefe HH, Mukherjee R, Arthur SR, Child MJ, Powell JR, Koster WH: LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol 1995, 37:H836-H847. Detailed analysis of cellular events in the pacing-induced DCM model in the dog.
51. Eble DM, Spinale FG: Contractile and cytoskeletal content, structure and mRNA levels with tachycardia-induced cardiomyopathy. Am J Physiol 1995, 268:2426-2439. Detailed analysis of cellular events in the pacing-induced DCM model in the pig.
52. Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze TH, Anversa P: The cellular basis of pacing-Induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995, 92:2306-2317.
53. Decker RS, Cook MG, Behnke-Barclay M, Decker ML: Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading. Circ Res 1995, 77:544-555. Use of isolated adult heart myocytes in culture to study growth mechanisms.
54. Eppenberger HM, Hertig C, Eppenberger-Eberhardt M: Adult rat cardiomyocytes in culture: a model system to study the plasticity of differentiated cardiophenotype at the molecular and cellular level. Trends Cardiovasc Med 1994, 4:187-193.
55. Harder BA, Schaub MC, Eppenberger HM, M. E-E: Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-1) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular myocytes in culture. J Mol Cell Cardiol 1995, 28:00-00. Analysis of the effects of growth factors on protein expression, with special emphasis on fetal gene expression.
56. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh S-M, Darbonne WC, Knutzon DS, Yen KR, Baker JB, Wood WI: Expression cloning of cardiotropin1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A 1995, 92:1142-1146.
57. Hein S, Münkel B, Schäfer G, Schaper J: A confocal laser microscopic study of dedifferentiation and redifferentiation of cultured adult rat myocytes. Circulation 1995, 92:I-185.
58. Labeit S, Kolmerer B: Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 1995, 270:293-296. Analysis of the entire sequence of the titin molecule.